Outgoing FDA Commissioner Margaret Hamburg said she thought about leaving the agency earlier, but didn’t want to step down before she had the right leadership team in place.
The disclosure, made March 4 at her last Science Board meeting as FDA commissioner, is revealing of both FDA’s struggles to recruit and retain top leadership – but also of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?